Brazil report links rare feline histiocytic sarcoma cases with FeLV

A new report from Brazil describes disseminated histiocytic sarcoma in two FeLV-positive cats, a pairing that stands out because feline histiocytic sarcoma is rare and FeLV hasn’t been considered a typical driver of this tumor type. According to the case report, both cats were young domestic shorthairs, and both initially raised suspicion for lymphoma based on their clinical presentation and gross findings. That makes the paper less about prevalence than about pattern recognition: in some FeLV-positive cats, an apparent lymphoma case may turn out to be something else. (journals.sagepub.com)

That background is important because feline histiocytic diseases are far less commonly diagnosed than their canine counterparts. Reviews of the literature describe histiocytic sarcoma in cats as an uncommon malignant neoplasm that may be localized or disseminated, with reported involvement of lymph nodes, spleen, liver, lungs, bone marrow, skin, periarticular tissues, and, in some cases, the central nervous system. A 2023 series of six cats with CNS involvement also noted that gross differentials can include lymphoma, granulomatous disease, and meningioma, underscoring how easily these tumors can be misclassified before tissue confirmation. (journals.sagepub.com)

The Brazil report appears to extend that diagnostic challenge. In the abstracted details available, one cat, a 1-year-old female, presented with hemiplegia and dysuria and was euthanized because spinal lymphoma was suspected. The second, a 4-year-old male, had systemic signs including hyporexia and ocular involvement. In both cases, the disease was disseminated and FeLV-positive status was documented, which is notable because published descriptions of feline histiocytic sarcoma have more often emphasized rarity, aggressive behavior, and anatomic distribution than any consistent retroviral association. (journals.sagepub.com)

Diagnosis in cases like these hinges on pathology. In the CNS histiocytic sarcoma series, neoplastic cells labeled positive for Iba1 and negative for E-cadherin, CD3, CD79, and MUM1, helping confirm histiocytic origin and exclude key mimics. More recent feline histiocytic sarcoma case reports have similarly stressed that imaging and cytology may narrow the field, but histopathology plus immunohistochemistry are what make the diagnosis. That’s especially relevant when clinicians are working up FeLV-positive cats, because FeLV is strongly associated with malignancy and immunosuppression, and lymphoma remains a common concern in that population. (journals.sagepub.com)

There doesn’t appear to be broad expert commentary yet on this specific Brazil report, but the existing literature gives the finding context. The 2020 AAFP retrovirus guidelines and Merck’s current FeLV review both emphasize that FeLV-positive cats can present with a wide range of disease manifestations, that a single test may not fully define infection status, and that malignancy is part of the progressive FeLV disease spectrum. At the same time, neither source identifies histiocytic sarcoma as a standard FeLV-linked neoplasm, which suggests this report is hypothesis-generating rather than practice-changing on causation. (pmc.ncbi.nlm.nih.gov)

Why it matters: For veterinarians, the practical takeaway is diagnostic, not just academic. If a young FeLV-positive cat presents with neurologic disease, ocular abnormalities, organomegaly, or disseminated lesions that seem consistent with lymphoma, histiocytic sarcoma should stay on the differential list, particularly when cytology is equivocal or the lesion distribution is unusual. This could affect decisions around biopsy, necropsy, immunohistochemistry panels, prognostic counseling, and how confidently clinicians label a case as lymphoma without tissue confirmation. (journals.sagepub.com)

The report also matters for surveillance and research. Because feline histiocytic sarcoma is so uncommon, even two well-characterized cases can influence how pathologists and oncologists think about age, presentation, and potential cofactors. If more FeLV-positive cases are published, the field may start asking whether retroviral infection contributes directly to tumor biology, indirectly through immune dysregulation, or simply coexists in regions where FeLV remains prevalent. For now, the evidence supports caution in interpretation, but also a broader diagnostic lens. (pmc.ncbi.nlm.nih.gov)

What to watch: Additional case reports, retrospective pathology reviews, or molecular work that test whether FeLV is a true association in feline histiocytic sarcoma, and whether these tumors are being underrecognized in cats initially worked up as lymphoma. (journals.sagepub.com)